Granulocyte Macrophage-Colony Stimulating Factor and Ipilimumab as Therapy in Melanoma (GIPI)
This study is currently recruiting participants.
Verified April 2013 by Northern California Melanoma Center
Sponsor:
Lynn E. Spitler, MD
Collaborator:
University of California, San Francisco
Information provided by (Responsible Party):
Lynn E. Spitler, MD, Northern California Melanoma Center
ClinicalTrials.gov Identifier:
NCT01363206
First received: May 27, 2011
Last updated: April 9, 2013
Last verified: April 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | May 2015 |
| Estimated Primary Completion Date: | May 2014 (Final data collection date for primary outcome measure) |